title: The pharmacophore of the human C5a anaphylatoxin.
abstract: We have determined which amino acids contribute to the pharmacophore of human C5a, a potent inflammatory mediator. A systematic mutational analysis of this 74-amino acid protein was performed and the effects on the potency of receptor binding and of C5a-induced intracellular calcium ion mobilization were measured. This analysis included the construction of hybrids between C5a and the homologous but unreactive C3a protein and site-directed mutagenesis. Ten noncontiguous amino acids from the structurally well-defined 4-helix core domain (amino acids 1-63) and the C-terminal arginine-containing tripeptide were found to contribute to the pharmacophore of human C5a. The 10 mostly charged amino acids from the core domain generally made small incremental contributions toward binding affinity, some of which were independent. Substitutions of the C-terminal amino acid Arg 74 produced the largest single effect. We also found the connection between these 2 important regions to be unconstrained.
authors.affiliation: Department of Biological Technologies, Ciba-Geigy Corporation, Summit, New Jersey 07901.
authors.forename: M J
authors.initials: MJ
authors.lastname: Toth
authors.forename: L
authors.initials: L
authors.lastname: Huwyler
authors.forename: W C
authors.initials: WC
authors.lastname: Boyar
authors.forename: A F
authors.initials: AF
authors.lastname: Braunwalder
authors.forename: D
authors.initials: D
authors.lastname: Yarwood
authors.forename: J
authors.initials: J
authors.lastname: Hadala
authors.forename: W O
authors.initials: WO
authors.lastname: Haston
authors.forename: M A
authors.initials: MA
authors.lastname: Sills
authors.forename: B
authors.initials: B
authors.lastname: Seligmann
authors.forename: N
authors.initials: N
authors.lastname: Galakatos
mesh_terms: D000409:Alanine / Q000737:chemistry; D000595:Amino Acid Sequence; D001483:Base Sequence; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D015926:Complement C3a / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology; D015936:Complement C5a / Q000737:chemistry* / Q000235:genetics / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009504:Neutrophils / Q000378:metabolism; D017354:Point Mutation; D017433:Protein Structure, Secondary; D011993:Recombinant Fusion Proteins; D013329:Structure-Activity Relationship; D013816:Thermodynamics
chemical_list: D011993:Recombinant Fusion Proteins; D015926:Complement C3a; D015936:Complement C5a; D000409:Alanine; D002118:Calcium